Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
About
Denali Therapeutics is a biopharmaceutical company focused on discovering, developing, and delivering medicines for people living with serious diseases, particularly neurodegenerative conditions. Their core strategy involves creating therapies that can effectively cross the blood-brain barrier using their proprietary Transport Vehicle (TV) technology. The company aims to address debilitating conditions such as Alzheimer's, Parkinson's, and ALS.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Denali Therapeutics do?
Denali Therapeutics is a biopharmaceutical company focused on discovering, developing, and delivering medicines for people living with serious diseases, particularly neurodegenerative conditions. Their core strategy involves creating therapies that can effectively cross the blood-brain barrier using their proprietary Transport Vehicle (TV) technology. The company aims to address debilitating conditions such as Alzheimer's, Parkinson's, and ALS.
How much funding has Denali Therapeutics raised?
Denali Therapeutics has raised a total of $1.0B in funding. The most recent round on record is Royalty Funding.
Where is Denali Therapeutics headquartered?
Denali Therapeutics is headquartered in South San Francisco, United States.
When was Denali Therapeutics founded?
Denali Therapeutics was founded in 2015.
What industry does Denali Therapeutics operate in?
Denali Therapeutics operates in Biotech, HealthTech, Drug Discovery, Neurotech, Biopharmaceutical, Therapeutics.
Similar Startups